Scripps Research Front Row Lecture Series: The Science of Sight
About the Event
Hollis Cline, PhD, Chair and Professor, Department of Neuroscience, Scripps Research
Kirill Martemyanov, PhD, Chair and Professor, Department of Neuroscience, Scripps Research
The Science of Sight: An Eye-Opening Presentation on the Neuroscience of Vision
Our sense of sight is our window into the world. Advances in neuroscience are rapidly unlocking the secrets of vision and paving the way new therapies for blindness and other vision disorders. In their Front Row lecture, Hollis Cline, PhD, and Kirill Martemyanov, PhD, co-chairs of the department of neuroscience at Scripps Research, will present their cutting-edge vision research. Among other topics, they will discuss recent findings on how molecules in the retina turn light into information, how visual sensations shape brain development, and how deciphering how our visual system works could lead to new ways to detect, prevent, and correct vision impairments.
Event Details
WHO: Scripps Research invites the public to join a free virtual series of live science lectures, called Front Row.
WHAT: Scripps Research scientists share their discoveries and successes as they work to solve the most pressing challenges of modern human health. Researchers at the forefront of their fields share data and interactively answer questions about COVID-19, cancer, vision loss, chronic inflammation and more. Sign up for a seat in the Front Row and enjoy compelling presentations, and an insider’s look at what’s next in biomedical research.
WHERE: The series takes place entirely online, so guests can join from the comfort of their own homes, either over the phone or on the computer. Advance registration is required. For more information, email frontrow@scripps.edu.
WHEN: Each one-hour lecture begins at 1 p.m. PT, 4:00 p.m. ET.
WHY: What makes cancer so difficult to defeat? Why does the immune system sometimes misfire and attack healthy tissue? How does the eye turn light into information? Answering these questions helps scientists develop urgently needed new treatments for conditions awaiting better options. One of America’s great innovators, Scripps Research President and CEO Peter Schultz, PhD, kicks off the series with a talk on how the nonprofit biomedical institute has expanded the bounds of academic research to transform and accelerate drug development efforts, to address unmet medical needs around the world.
To watch past Front Row lectures, subscribe to the Scripps Research YouTube channel.